The termination of an NIH diversity supplement at UT Health Houston disrupted both research on major parasitic disease and a key pathway for training early-career scientists.
A research lab at the University of Texas Health Science Center at Houston lost an NIH diversity supplement that had been supporting the stipend, tuition, and research costs of a PhD student when the funding was abruptly terminated in early 2025 following changes to NIH diversity supplement policies. The supplement was tied to an active grant supporting research on schistosomiasis, a parasitic disease that affects hundreds of millions of people worldwide. The research focused on identifying substances secreted by parasitic blood flukes that allow them to evade the immune system and persist in the human body —insights with important implications for global health and the development of new treatments and prevention strategies.
The loss of the supplement, which had been expected to provide two years of stable support, created an immediate and unplanned funding gap. Because research institutes are required to continue supporting enrolled graduate students, the lab was forced to redirect funds from the core grant to cover the student's costs. This reduced the lab's overall research capacity, slowing progress on the research project, and limited the ability to recruit or take on new trainees, constraining an important pathway for developing the next generation of researchers.
At the time of the policy change, the student was preparing an NIH predoctoral fellowship application through a pathway designed to support students from underrepresented backgrounds in medical research. After the application was already submitted, the agency eliminated this pathway, leaving the student in limbo with no clear guidance on how to proceed and no option for the application to be automatically considered under the standard review track. As a result, the student was forced to withdrawal the application and wait until a future cycle to reapply through the general program. This disruption cost valuable time and resources for both the student and lead investigator and introduced uncertainty into the student's training path, potentially influencing their decision to pivot to pursue opportunities outside of academic research and illustrating the tough choices early-careers scientists are grappling with as federal research support diminishes.